$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
01:19pm, Friday, 24'th Jun 2022 Zacks Investment Research
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
Ready to Get Rich in the Stock Market? 5 Investments You Can't Go Wrong With
12:51pm, Friday, 24'th Jun 2022 The Motley Fool
"Can't go wrong" is a serious standard, but a few solid companies really do rise to the meaning of the phrase.
3 Dow Stocks to Buy for a Bear Market
12:30pm, Friday, 24'th Jun 2022
Investors can find safety from the bear market in these three Dow stocks. They offer low volatility, stable dividends and outperformance.
3 Stocks That Drove the Dow's Nearly 200-Point Gain
08:55pm, Thursday, 23'rd Jun 2022 The Motley Fool
Investors seem to be adapting to the reality of a recession on the horizon.
6 Dividend Income Stocks With Better Yields Than the S&P 500
01:29pm, Thursday, 23'rd Jun 2022
These are 6 dividend income stocks with better yields than the S&P 500. These 6 stocks outperformed the S&P 500 this year and have higher yields, with earnings that can cover the dividends, making the
Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids
12:39pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Merck's (MRK) Vaxneuvance vaccine includes pneumococcal serotypes 22F and 33F, which are not included in the currently licensed 13-valent conjugate vaccines.
Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids
10:03am, Thursday, 23'rd Jun 2022
Merck's (MRK) Vaxneuvance vaccine includes pneumococcal serotypes 22F and 33F, which are not included in the currently licensed 13-valent conjugate vaccines.
Merck (MRK) Gains As Market Dips: What You Should Know
09:45pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Merck (MRK) closed the most recent trading day at $89.16, moving +1.28% from the previous trading session.
The Dow Lost Ground as Investors Piled into Recession-Proof Stocks
08:45pm, Wednesday, 22'nd Jun 2022 The Motley Fool
Market participants think the economy could be in for a tough time.
3 High-Yielding Dividend Stocks to Get You Through the Bear Market
03:30pm, Wednesday, 22'nd Jun 2022 The Motley Fool
These stocks also make for fantastic long-term investments.
Iovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs
02:48pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Iovance (IOVA) is progressing well with the clinical development of its pipeline candidates. It expects to file a BLA with the FDA, seeking approval for its lead candidate to treat metastatic melanoma
What Stocks to Invest Today? 3 Pharmaceutical Stocks To Watch
12:15pm, Wednesday, 22'nd Jun 2022
Could these pharmaceutical stocks be worth watching today?
3 Stocks That Drove the Dow's 641-Point Gain
08:57pm, Tuesday, 21'st Jun 2022 The Motley Fool
Investors seemed to take a breather today after all of the selling last week.
3 Stocks That Drove the Dow's 641-Point Gain
04:57pm, Tuesday, 21'st Jun 2022
Investors seemed to take a breather today after all of the selling last week.
A Trio of Stocks for Growth-Oriented Investors
12:16pm, Tuesday, 21'st Jun 2022
Growth-oriented investors may want to consider the following stocks, since they represent businesses with price-earnings ratios below 20 that recorded significant improvements in their trailing 12-mon
Sign In
Buy MRK